Investment Commitment. TDCC, its Affiliates (including Mycogen for purpose of this paragraph only), DAS and the DAS Affiliates will at a minimum achieve a combined funding level of on average $35,000,000 (thirty-five million U.S. dollars) or more per Contract Year during the Research Collaboration (subject to ramp-up during the first Contract Year), to support the discovery, development and commercialization of genetically modified plants and products (lower case) derived therefrom.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Large Scale Biology Corp), Collaboration and License Agreement (Large Scale Biology Corp)